Simon Sturge

Chairman at

Moonlake Immunotherapeutics AG

Net worth: 3 M $ as of 30/05/2026

67 year

75 connections

Health Technology

Commercial Services

Technology Services

Profile

Simon John Sturge is the founder of Ligand UK Ltd., RiboTargets Ltd. Current positions include Executive Chairman at Mediar Therapeutics, Inc. since 2021, Chairman at Moonlake Immunotherapeutics AG since 2021, and Trustee at Weizmann UK.
Former roles include Chief Executive Officer & Director at Lonza Biologics Plc, Chief Executive Officer at Dr. Reddy's Research & Development BV from 2008 to 2011, Chief Executive Officer & Director at Kymab Ltd. from 2019 to 2021, Chief Executive Officer & Director at Kymab Group Ltd., Chairman-Supervisory Board at Cristal Delivery BV, Chairman at MoonLake Immunotherapeutics from 2022 to 2026, Director at Celltech Group Plc, Independent Non-Executive Director at Silence Therapeutics Plc from 2015 to 2016, Independent Non-Executive Director at Feedback Plc from 2017 to 2021, Independent Non-Executive Director at Galapagos NV from 2023 to 2025, Chief Operating Officer-Healthcare at Merck KGaA from 2013 to 2019, Manager-Business Development at Astra Pharmaceuticals Ltd., Senior Vice President at Boehringer Ingelheim BV from 2010 to 2013, and Chief Operating Officer at Merck Healthcare.
Education includes an undergraduate degree from the University of Sussex conferred in 1980.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MOONLAKE IMMUNOTHERAPEUTICS CLASS A 0.23%	04/06/2025	171,980 ( 0.23% )	3 M $	30/05/2026
LAKEFRONT BIOTHERAPEUTICS 0%	30/12/2025	501 ( 0% )	14 300 $	30/05/2026

Simon Sturge active positions

Companies	Position	Start
Moonlake Immunotherapeutics AG Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company	Chairman	09/08/2021
Mediar Therapeutics, Inc. Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic	Chairman	14/09/2021
Weizmann UK Weizmann UK Miscellaneous Commercial ServicesCommercial Services Operates scientific research institutes	Director/Board Member	-

All active positions of Simon Sturge

Former positions of Simon Sturge

Companies	Position	End
MOONLAKE IMMUNOTHERAPEUTICS	Chairman	27/02/2026
LAKEFRONT BIOTHERAPEUTICS NV	Director/Board Member	27/07/2025
Kymab Ltd. Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs	Chief Executive Officer	30/06/2021
FEEDBACK PLC	Director/Board Member	29/06/2021
MERCK KGAA	Corporate Officer/Principal	31/03/2019

See the detail of Simon Sturge's experience

Training of Simon Sturge

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Simon Sturge's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
Ligand UK Ltd. Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products	Health Technology
Merck KGaA Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products	Health Technology
Celltech Group Plc Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals	Health Technology
Galapagos NV Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology	Health Technology
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
Feedback Plc Feedback Plc Packaged SoftwareTechnology Services Develops medical imaging communications application	Technology Services
Lonza Biologics Plc Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies	Commercial Services
RiboTargets Ltd. RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company	Health Technology
Dr. Reddy's Research & Development BV Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs	Health Technology
University of Sussex University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Astra Pharmaceuticals Ltd. Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures & wholesales pharmaceutical products	Health Technology
Boehringer Ingelheim BV Boehringer Ingelheim BV Drugstore ChainsRetail Trade Develops and markets drugs	Retail Trade
Kymab Ltd. Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs	Health Technology
Weizmann UK Weizmann UK Miscellaneous Commercial ServicesCommercial Services Operates scientific research institutes	Commercial Services
Cristal Delivery BV Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Develops and manufactures nanomedicines for therapeutic drug optimization	Health Technology
Mediar Therapeutics, Inc. Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic	Health Technology
Kymab Group Ltd. Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs	Health Technology
Merck Healthcare
Moonlake Immunotherapeutics AG Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology
MoonLake Immunotherapeutics MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company	Health Technology